Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy

计划入组 20 人 · 首次发布于 2025 年 9 月 2 日

Avazzia-University of Texas Southwestern Medical Center-Tennant Biomodulator® PRO Perfusion Study

计划入组 6 人 · 首次发布于 2019 年 2 月 18 日

Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock

计划入组 58 人 · 首次发布于 2011 年 6 月 7 日

HuCo Liver Perfusion

Rb-82 Radioisotope

Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences)

Aethlon Medical

Vivani Medical

United States

Journey Medical

United States

Perfusion Medical's PM-208 Receives $1.8 Million Grant from U.S. Air Force for Blood Loss Treatment

Virginia Catalyst Awards $2.4 Million to Advance Surgical Hydrogel, Trauma Resuscitation Drug, and AI-Enabled Fracture Healing Device Toward Human Trials

Annexin Pharmaceuticals Reports Promising Early Results from Phase 2a Study of ANXV in Diabetic Retinopathy and Retinal Vein Occlusion